Home > Healthcare > Biotechnology > Biopharma > Cell Signaling Market

Cell Signaling Market Share

Report ID: GMI9126
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Cell Signaling Market Share

The cell signaling industry is characterized by intense competition among key players striving to strengthen their foothold in the market. Key market players frequently undertake inorganic growth initiatives such as partnerships, mergers, and acquisitions to expand their market presence, enhance product portfolios, and gain a competitive advantage.

Cell Signaling Market Companies

Prominent players operating in the cell signaling industry include:

Becton, Dickinson and Company
Bio-Rad Laboratories Inc.
Bio-Techne Corporation
Cell Signaling Technology Inc.
Danaher Corporation
Merck KGaA
PerkinElmer Inc.
Promega Corporation
QIAGEN N.V.
Thermo Fisher Scientific, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global cell signaling market was valued at USD 4.4 billion in 2023 and is anticipated to grow at 6.3% CAGR between 2024 – 2032, owing to the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders.

The consumables segment in the market accounted for USD 2.6 billion in 2023, driven by the continuous development of new consumables with enhanced sensitivity and specificity.

North America cell signaling market is anticipated to reach USD 3.7 billion by 2032, attributed to a well-established healthcare infrastructure, robust R&D activities, and high healthcare expenditure.

Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., Danaher Corporation, Merck KGaA, PerkinElmer Inc., Promega Corporation, QIAGEN N.V. and Thermo Fisher Scientific, Inc.